3 recruiting, 2 not yet recruiting. 3 Phase 2, 2 Phase 1, 1 Phase 3.
By phase and status
Follow SR604: new trials by email Literature Review of SR604 trials Research Report on SR604
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Phase III Clinical Trial Evaluating SR604 Injection for Prophylactic Treatment in Patients With Hemophilia
SR604 - Hemophilia A, Hemophilia A and B | Phase 3 | Not yet recruiting | Shanghai RAAS Blood Products Co., Ltd. | 90 | 2026-09-30 | 2026-10-15 |
A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency
SR604 - Factor VII Deficiency | Phase 2 | Not yet recruiting | Shanghai RAAS Blood Products Co., Ltd. | 12 | 2026-07-01 | 2026-07-17 |
A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease
SR604 - Von Willebrand Disease (VWD) | Phase 2 | Recruiting | Shanghai RAAS Blood Products Co., Ltd. | 24 | 2025-11-26 | 2026-06-11 |
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency
SR604 - Hemophilia A, Hemophilia B | Phase 1 / Phase 2 | Recruiting | Shanghai RAAS Blood Products Co., Ltd. | 76 | 2024-05-31 | 2026-06-12 |
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
SR604, Placebo - Healthy Participants, Hemophilia A | Phase 1 | Recruiting | Equilibra Bioscience LLC | 31 | 2024-05-10 | 2026-07-02 |
Conditions studied
Factor VII Deficiency (3) · Hemophilia A (3) · Hemophilia B (3) · von Willebrand Diseases (1)
Sponsors
Shanghai RAAS Blood Products Co., Ltd. (4) · Equilibra Bioscience LLC (1)
Countries
China (3) · Canada (1) · United States (1)